Anders Bjartell

Research interests

Publications

• Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)

  European Urology · 2024 · https://doi.org/10.1016/j.eururo.2024.09.017

• Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study

  The Lancet Oncology · 2024 · 10.1016/s1470-2045(24)00220-1

• Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

  European Journal of Cancer · 2023 · https://doi.org/10.1016/j.ejca.2023.02.018

• Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study

  Journal of Clinical Oncology · 2021 · https://doi.org/10.1200/jco.20.03488

• Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer

  European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 10.1007/s00259-020-04934-4

• Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

  European Urology · 2020 · https://doi.org/10.1016/j.eururo.2020.01.012

• EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)

  European Urology · 2019 · https://doi.org/10.1016/j.eururo.2019.09.020

• Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer

  New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1903307

• Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study

  European Urology · 2016 · https://doi.org/10.1016/j.eururo.2016.07.032

• Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial

  European Urology · 2015 · https://doi.org/10.1016/j.eururo.2015.02.029

• Genomic Predictors of Outcome in Prostate Cancer

  European Urology · 2015 · https://doi.org/10.1016/j.eururo.2015.04.008

• Galiellalactone Is a Direct Inhibitor of the Transcription Factor STAT3 in Prostate Cancer Cells

  Journal of Biological Chemistry · 2014 · https://doi.org/10.1074/jbc.m114.564252

• Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study

  BMJ · 2013 · 10.1136/bmj.f2023

• Carbon Monoxide Expedites Metabolic Exhaustion to Inhibit Tumor Growth

  Cancer Research · 2013 · 10.1158/0008-5472.can-13-1075

• A Systematic Review of the Volume–Outcome Relationship for Radical Prostatectomy

  European Urology · 2013 · 10.1016/j.eururo.2013.04.012

• The Mutational Landscape of Prostate Cancer

  European Urology · 2013 · 10.1016/j.eururo.2013.05.029

• A Novel Automated Platform for Quantifying the Extent of Skeletal Tumour Involvement in Prostate Cancer Patients Using the Bone Scan Index

  European Urology · 2012 · https://doi.org/10.1016/j.eururo.2012.01.037

• Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study

  European Urology · 2012 · https://doi.org/10.1016/j.eururo.2012.11.005

• The Contemporary Concept of Significant Versus Insignificant Prostate Cancer

  European Urology · 2011 · https://doi.org/10.1016/j.eururo.2011.05.006

• MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review

  European Urology · 2011 · https://doi.org/10.1016/j.eururo.2011.01.044

• Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells

  Cancer Research · 2011 · 10.1158/0008-5472.can-10-2421

• SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas

  The American Journal of Surgical Pathology · 2011 · 10.1097/pas.0b013e31821c3dae

• Advances in Magnetic Resonance Imaging: How They Are Changing the Management of Prostate Cancer

  European Urology · 2011 · 10.1016/j.eururo.2011.02.034

• Epigenetics in Prostate Cancer: Biologic and Clinical Relevance

  European Urology · 2011 · 10.1016/j.eururo.2011.06.035

• Tumor markers in prostate cancer I: Blood-based markers

  Acta Oncologica · 2011 · https://doi.org/10.3109/0284186x.2010.542174

• Galiellalactone Inhibits Stem Cell-Like ALDH-Positive Prostate Cancer Cells

  PLoS ONE · 2011 · https://doi.org/10.1371/journal.pone.0022118

• miR‐34c is downregulated in prostate cancer and exerts tumor suppressive functions

  International Journal of Cancer · 2010 · https://doi.org/10.1002/ijc.25269

• Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study

  BMJ · 2010 · 10.1136/bmj.c4521

• ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice

  European Urology · 2009 · 10.1016/j.eururo.2009.04.036

• The Role of SPINK1 in ETS Rearrangement-Negative Prostate Cancers

  Cancer Cell · 2008 · 10.1016/j.ccr.2008.04.016

• Galiellalactone is a novel therapeutic candidate against hormone‐refractory prostate cancer expressing activated Stat3

  The Prostate · 2007 · https://doi.org/10.1002/pros.20699

• The Human Cationic Antimicrobial Protein (hCAP-18) Is Expressed in the Epithelium of Human Epididymis, Is Present in Seminal Plasma at High Concentrations, and Is Attached to Spermatozoa

  Infection and Immunity · 2000 · 10.1128/iai.68.7.4297-4302.2000

Current projects

No projects listed.